Single Dose Steroid Injection After Loss of Signal (LOS) During Thyroid Surgery is Effective to Recover Electric Signal Avoiding Vocal Cord Palsy and the Need of Staged Thyroidectomy: Prospective Evaluation on 702 Patients.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 20 11 2019
medline: 20 11 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

Steroids are often used for the management of vocal cord palsy after thyroid surgery. There are no reports in the current literature of their intraoperative use, immediately after a loss of signal during neuromonitoring (LOS). We evaluate the impact of a single dose of 4 mg of dexamethasone on laryngeal nerve function, administrated at the time of a LOS during a nerve-monitored thyroidectomy. A prospective not randomized study was performed, dividing patients in two groups, when a LOS was detected. LOS was defined as an electromyographic signal (EMG) inferior to 100 μV when stimulating the inferior laryngeal nerve, according to international guidelines. In group 1 (G1), surgeon waits for signal's recovery up to 20 min. Absence of a detectable signal after 20 min was predictive of vocal cord palsy; if it affected the first side of surgery the procedure was interrupted to avoid the risk of bilateral nerve palsy. In group 2 (G2), 4 mg of dexamethasone were injected within 10 min from a detected LOS, waiting 10 min for its effects. An EMG value > to 200 μV within 20' after steroid administration was predictive of full recovery and normal post-operatory vocal cord function. Vocal cords motility was checked at postoperative day 1 in all patients by an experienced ENT. Between January 2017 and December 2018, 702 patients underwent thyroid surgery under intermittent intraoperative nerve monitoring by two expert surgeons. A LOS was found in 22 patients in G1 and 16 in G2. Four patients in G1 spontaneously recovered electric signal (18.2%), while in G2 a signal was recovered in 14/16 patients (87.5%) (p < 0.001). This immediate effect was monitored by EMG, showing the increase in potentials at 10, 15 and 20 min after injection. ENT evaluation found vocal cord palsy, respectively, in 18/22 and 1/16 patients (G1 vs G2, p < 0.001). One of the patients in G2 who recovered electric signal presented transient palsy, fully recovered at 2 months, while the two patients who had a signal < 200 μV did not present postoperative cord palsy. In G1, 10/18 palsy were definitive. No permanent palsies were presents in G2. A single 4 mg iv dexamethasone injection within 10 min form a LOS during thyroid surgery exerts a therapeutic action, measurable by EMG modifications. It avoids vocal nerve palsy and the need of a staged thyroidectomy. It may also protect from permanent cord palsy, but the mechanism is unknown.

Sections du résumé

BACKGROUND BACKGROUND
Steroids are often used for the management of vocal cord palsy after thyroid surgery. There are no reports in the current literature of their intraoperative use, immediately after a loss of signal during neuromonitoring (LOS). We evaluate the impact of a single dose of 4 mg of dexamethasone on laryngeal nerve function, administrated at the time of a LOS during a nerve-monitored thyroidectomy.
METHODS METHODS
A prospective not randomized study was performed, dividing patients in two groups, when a LOS was detected. LOS was defined as an electromyographic signal (EMG) inferior to 100 μV when stimulating the inferior laryngeal nerve, according to international guidelines. In group 1 (G1), surgeon waits for signal's recovery up to 20 min. Absence of a detectable signal after 20 min was predictive of vocal cord palsy; if it affected the first side of surgery the procedure was interrupted to avoid the risk of bilateral nerve palsy. In group 2 (G2), 4 mg of dexamethasone were injected within 10 min from a detected LOS, waiting 10 min for its effects. An EMG value > to 200 μV within 20' after steroid administration was predictive of full recovery and normal post-operatory vocal cord function. Vocal cords motility was checked at postoperative day 1 in all patients by an experienced ENT.
RESULTS RESULTS
Between January 2017 and December 2018, 702 patients underwent thyroid surgery under intermittent intraoperative nerve monitoring by two expert surgeons. A LOS was found in 22 patients in G1 and 16 in G2. Four patients in G1 spontaneously recovered electric signal (18.2%), while in G2 a signal was recovered in 14/16 patients (87.5%) (p < 0.001). This immediate effect was monitored by EMG, showing the increase in potentials at 10, 15 and 20 min after injection. ENT evaluation found vocal cord palsy, respectively, in 18/22 and 1/16 patients (G1 vs G2, p < 0.001). One of the patients in G2 who recovered electric signal presented transient palsy, fully recovered at 2 months, while the two patients who had a signal < 200 μV did not present postoperative cord palsy. In G1, 10/18 palsy were definitive. No permanent palsies were presents in G2.
CONCLUSION CONCLUSIONS
A single 4 mg iv dexamethasone injection within 10 min form a LOS during thyroid surgery exerts a therapeutic action, measurable by EMG modifications. It avoids vocal nerve palsy and the need of a staged thyroidectomy. It may also protect from permanent cord palsy, but the mechanism is unknown.

Identifiants

pubmed: 31741073
doi: 10.1007/s00268-019-05295-2
pii: 10.1007/s00268-019-05295-2
doi:

Substances chimiques

Dexamethasone 7S5I7G3JQL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-425

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Thyroid. 2013 Jul;23(7):906-8
pubmed: 23461779
Spine J. 2019 Feb;19(2):253-260
pubmed: 29800704
Br J Surg. 2013 Apr;100(5):662-6
pubmed: 23341266
Br J Surg. 2012 Aug;99(8):1089-95
pubmed: 22696115
Medicine (Baltimore). 2018 Sep;97(36):e11832
pubmed: 30200067
Laryngoscope. 2011 Jan;121 Suppl 1:S1-16
pubmed: 21181860
Head Neck. 2016 Apr;38 Suppl 1:E1144-51
pubmed: 26331940
Ann Surg. 2002 Feb;235(2):261-8
pubmed: 11807367
Br J Surg. 2019 Mar;106(4):404-411
pubmed: 30681138
Head Neck. 2012 Nov;34(11):1591-6
pubmed: 22431167
World J Surg. 2006 Mar;30(3):299-303
pubmed: 16479340
Laryngoscope. 2015 Jan;125(1):111-7
pubmed: 25291409
Global Spine J. 2017 Apr;7(1 Suppl):53S-57S
pubmed: 28451492
Eur Spine J. 2003 Feb;12(1):84-90
pubmed: 12592551
Arch Surg. 2000 Feb;135(2):204-7
pubmed: 10668882
JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):124-8
pubmed: 24384927
Langenbecks Arch Surg. 2017 Sep;402(6):957-964
pubmed: 27143020
Endocrine. 2018 Dec;62(3):560-565
pubmed: 30173330
Langenbecks Arch Surg. 2015 Dec;400(8):929-36
pubmed: 26545607
World J Surg. 2008 Jul;32(7):1358-66
pubmed: 18305996
Gland Surg. 2017 Oct;6(5):453-463
pubmed: 29142834
World J Surg. 2014 Mar;38(3):599-606
pubmed: 24081538
Laryngoscope. 2018 Oct;128 Suppl 3:S1-S17
pubmed: 30289983
Laryngoscope. 2019 Feb;129(2):525-531
pubmed: 30247760
Laryngoscope. 2016 May;126(5):1260-6
pubmed: 26667156
Langenbecks Arch Surg. 2017 Jun;402(4):663-673
pubmed: 28378238
Otolaryngol Head Neck Surg. 2013 Jun;148(6 Suppl):S1-37
pubmed: 23733893
Ann Surg Oncol. 2011 Jun;18(6):1742-7
pubmed: 21369741
Surgery. 1994 Feb;115(2):139-44
pubmed: 8310401
PLoS One. 2014 Oct 16;9(10):e109582
pubmed: 25330115
World J Surg. 2010 Jun;34(6):1274-84
pubmed: 20143072

Auteurs

Gianluca Donatini (G)

General and Endocrine Surgery, CHU Poitiers, University of Poitiers, 2 Rue de la Miletrie, 86021, Poitiers, France. Giacko76@hotmail.com.

Jerome Danion (J)

General and Endocrine Surgery, CHU Poitiers, University of Poitiers, 2 Rue de la Miletrie, 86021, Poitiers, France.

Carlos Zerrweck (C)

ABC Hospital, Mexico City, Mexico.

Pierre Etienne (P)

General and Endocrine Surgery, CHU Poitiers, University of Poitiers, 2 Rue de la Miletrie, 86021, Poitiers, France.

Louis Lacoste (L)

Department of Anesthesia CHU Poitiers, University of Poitiers, Poitiers, France.

Jean-Louis Kraimps (JL)

General and Endocrine Surgery, CHU Poitiers, University of Poitiers, 2 Rue de la Miletrie, 86021, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH